01 1MSN Laboratories Private Limited
02 1Teva Czech Industries s.r.o
01 1Rolapitant
02 1Rolapitant Hydrochloride
01 1India
02 1Israel
NDC Package Code : 14501-0099
Start Marketing Date : 2020-03-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 47848-053
Start Marketing Date : 2016-07-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
A Rolapitant HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rolapitant HCl, including repackagers and relabelers. The FDA regulates Rolapitant HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rolapitant HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rolapitant HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rolapitant HCl supplier is an individual or a company that provides Rolapitant HCl active pharmaceutical ingredient (API) or Rolapitant HCl finished formulations upon request. The Rolapitant HCl suppliers may include Rolapitant HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Rolapitant HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rolapitant HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rolapitant HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rolapitant HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rolapitant HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rolapitant HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rolapitant HCl suppliers with NDC on PharmaCompass.
We have 2 companies offering Rolapitant HCl
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
